Glasgow Aneurysm Score: a predictor of long-term mortality following endovascular repair of abdominal aortic aneurysm?

To evaluate the value of Glasgow Aneurysm Score (GAS) in predicting long-term mortality and survival in patients who have undergone endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A retrospective single-center study of 257 patients with non-ruptured AAA undergoing EVA...

Full description

Saved in:
Bibliographic Details
Published in:BMC cardiovascular disorders 2021-11, Vol.21 (1), p.551-551, Article 551
Main Authors: üzen, Anil, Yilmaz, Metin, YiÄit, Görkem, Civelek, Ä°sa, Türkçü, Mehmet Ali, Çetinkaya, Ferit, Ãnal, Ertekin Utku, Ä°Åcan, Hakki Zafer
Format: Article
Language:English
Subjects:
Abdominal aneurysm
Aged
Aged, 80 and over
Analysis
Aortic aneurysm
Aortic Aneurysm, Abdominal - diagnostic imaging
Aortic Aneurysm, Abdominal - mortality
Aortic Aneurysm, Abdominal - surgery
Blood Vessel Prosthesis Implantation - adverse effects
Blood Vessel Prosthesis Implantation - mortality
Care and treatment
Decision Support Techniques
Diagnosis
Endovascular
Endovascular Procedures - adverse effects
Endovascular Procedures - mortality
Female
Humans
Male
Middle Aged
Mortality
Predictive Value of Tests
Retrospective Studies
Risk Assessment
Risk Factors
Survival
Time Factors
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c486t-633204527f46ac856c0b0c769e1880360cd69f0c388326daacd799da01010cf03
container_end_page 551
container_issue 1
container_start_page 551
container_title BMC cardiovascular disorders
container_volume 21
creator üzen, Anil
Yilmaz, Metin
YiÄit, Görkem
Civelek, Ä°sa
Türkçü, Mehmet Ali
Çetinkaya, Ferit
Ãnal, Ertekin Utku
Ä°Åcan, Hakki Zafer
description To evaluate the value of Glasgow Aneurysm Score (GAS) in predicting long-term mortality and survival in patients who have undergone endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A retrospective single-center study of 257 patients with non-ruptured AAA undergoing EVAR between January 2013 and 2021. GAS scores were compared between the survivors (group 1) and the long-term mortality (group 2) groups. Cox regression analysis was used to determine independent predictors of late mortality. Receiver operating characteristic curve (ROC) analysis was used to determine the optimum cut-off values of GAS values to determine the effect on late-mortality. Survival analysis was conducted using Kaplan-Meier. The study included 257 patients with a mean age of 69.75 ± 7.75 (46-92), who underwent EVAR due to AAA. Average follow up period was 18.98 ± 22.84 months (0-88). Fourty-five (17.8%) mortalities occured during long-term follow-up. A past medical history of cancer resulted in a 2.5 fold increase in risk of long-term mortality (OR: 2.52, 95% CI 1.10-5.76; p = 0.029). GAS values were higher in group 2 compared to group 1 (81.02 ± 10.33 vs. 73.73 ± 10.46; p 
doi_str_mv 10.1186/s12872-021-02366-y
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_01f176db023d4667afb9b243d8b8d519</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A686472856</galeid><doaj_id>oai_doaj_org_article_01f176db023d4667afb9b243d8b8d519</doaj_id><sourcerecordid>A686472856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-633204527f46ac856c0b0c769e1880360cd69f0c388326daacd799da01010cf03</originalsourceid><addsrcrecordid>eNptUk1rFTEUHUSxtfoHXEjAjZup-ZhJMi4sj6K1UHChrsOdfIwpmckzmXnl_XvzPix9ICHkcnPOycnlVNVbgi8JkfxjJlQKWmNKymac19tn1TlpBKkp5eT5k_qsepXzPcZESNy9rM5YIzpZyvNqcxMgD_EBrSa7pG0e0Q8dk_2EAK2TNV7PMaHoUIjTUM82jWiMaYbg5y1yMYT44KcB2cnEDWS9BEgo2TX4PQl6E0c_QUBQSF4jOD5y9bp64SBk--Z4XlS_vn75ef2tvvt-c3u9uqt1I_lcc8YobloqXMNBy5Zr3GMteGdJsc841oZ3DmsmJaPcAGgjus4AJmVph9lFdXvQNRHu1Tr5EdJWRfBq34hpULBzFqzCxBHBTV9GaRrOBbi-62nDjOylaUlXtD4ftNZLP1qj7TQnCCeipzeT_62GuFGSY9aKncCHo0CKfxabZzX6rG0IZSxxyYpyjKlsREsK9P0BOkCx5icXi6LewdWKS94IWoZRUJf_QZVl7Oh1nKzzpX9CoAeCTjHnZN2je4LVLlPqkClVMqX2mVLbQnr39N-PlH8hYn8BkXvIfQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2600284751</pqid></control><display><type>article</type><title>Glasgow Aneurysm Score: a predictor of long-term mortality following endovascular repair of abdominal aortic aneurysm?</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>üzen, Anil ; Yilmaz, Metin ; YiÄit, Görkem ; Civelek, Ä°sa ; Türkçü, Mehmet Ali ; Çetinkaya, Ferit ; Ãnal, Ertekin Utku ; Ä°Åcan, Hakki Zafer</creator><creatorcontrib>üzen, Anil ; Yilmaz, Metin ; YiÄit, Görkem ; Civelek, Ä°sa ; Türkçü, Mehmet Ali ; Çetinkaya, Ferit ; Ãnal, Ertekin Utku ; Ä°Åcan, Hakki Zafer</creatorcontrib><description>To evaluate the value of Glasgow Aneurysm Score (GAS) in predicting long-term mortality and survival in patients who have undergone endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A retrospective single-center study of 257 patients with non-ruptured AAA undergoing EVAR between January 2013 and 2021. GAS scores were compared between the survivors (group 1) and the long-term mortality (group 2) groups. Cox regression analysis was used to determine independent predictors of late mortality. Receiver operating characteristic curve (ROC) analysis was used to determine the optimum cut-off values of GAS values to determine the effect on late-mortality. Survival analysis was conducted using Kaplan-Meier. The study included 257 patients with a mean age of 69.75 ± 7.75 (46-92), who underwent EVAR due to AAA. Average follow up period was 18.98 ± 22.84 months (0-88). Fourty-five (17.8%) mortalities occured during long-term follow-up. A past medical history of cancer resulted in a 2.5 fold increase in risk of long-term mortality (OR: 2.52, 95% CI 1.10-5.76; p = 0.029). GAS values were higher in group 2 compared to group 1 (81.02 ± 10.33 vs. 73.73 ± 10.46; p &lt; 0.001). The area under the ROC curve for GAS was 0.682 and the GAS cut-off value was 77.5 (specificity 64%, p &lt; 0.001). The mortality rates in patients with GAS &lt; 77.5 and GAS &gt; 77.5 were: 12.8% and 24.8% respectively (p = 0.014). Every 10 point increase in GAS resulted in approximately a 2 fold increase in risk of long-term mortality (OR: 1.8, 95% CI 1.3-2.5; p &lt; 0.001). Five year survival rates in patients with GAS &lt; 77.5 and &gt; 77.5 were 75.7% and 61.7%, respectively (p = 0.013). The findings of our study suggests that an increase in GAS score may predict long-term mortality. In addition, the mortality rates in patients above the GAS cut-off value almost doubled compared to those below. Furthermore, the presence of a past history of cancer resulted in a 2.5 fold increase in long-term mortality risk. Addition of cancer to the GAS scoring system may be considered in future studies. Further studies are necessary to consolidate these findings.</description><identifier>ISSN: 1471-2261</identifier><identifier>EISSN: 1471-2261</identifier><identifier>DOI: 10.1186/s12872-021-02366-y</identifier><identifier>PMID: 34798809</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Abdominal aneurysm ; Aged ; Aged, 80 and over ; Analysis ; Aortic aneurysm ; Aortic Aneurysm, Abdominal - diagnostic imaging ; Aortic Aneurysm, Abdominal - mortality ; Aortic Aneurysm, Abdominal - surgery ; Blood Vessel Prosthesis Implantation - adverse effects ; Blood Vessel Prosthesis Implantation - mortality ; Care and treatment ; Decision Support Techniques ; Diagnosis ; Endovascular ; Endovascular Procedures - adverse effects ; Endovascular Procedures - mortality ; Female ; Humans ; Male ; Middle Aged ; Mortality ; Predictive Value of Tests ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Survival ; Time Factors ; Treatment Outcome</subject><ispartof>BMC cardiovascular disorders, 2021-11, Vol.21 (1), p.551-551, Article 551</ispartof><rights>2021. The Author(s).</rights><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c486t-633204527f46ac856c0b0c769e1880360cd69f0c388326daacd799da01010cf03</cites><orcidid>0000-0002-9500-720X ; 0000-0002-0749-5152 ; 0000-0002-4334-7974 ; 0000-0002-1144-8906 ; 0000-0003-2878-2676</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603579/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603579/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,37012,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34798809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>üzen, Anil</creatorcontrib><creatorcontrib>Yilmaz, Metin</creatorcontrib><creatorcontrib>YiÄit, Görkem</creatorcontrib><creatorcontrib>Civelek, Ä°sa</creatorcontrib><creatorcontrib>Türkçü, Mehmet Ali</creatorcontrib><creatorcontrib>Çetinkaya, Ferit</creatorcontrib><creatorcontrib>Ãnal, Ertekin Utku</creatorcontrib><creatorcontrib>Ä°Åcan, Hakki Zafer</creatorcontrib><title>Glasgow Aneurysm Score: a predictor of long-term mortality following endovascular repair of abdominal aortic aneurysm?</title><title>BMC cardiovascular disorders</title><addtitle>BMC Cardiovasc Disord</addtitle><description>To evaluate the value of Glasgow Aneurysm Score (GAS) in predicting long-term mortality and survival in patients who have undergone endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A retrospective single-center study of 257 patients with non-ruptured AAA undergoing EVAR between January 2013 and 2021. GAS scores were compared between the survivors (group 1) and the long-term mortality (group 2) groups. Cox regression analysis was used to determine independent predictors of late mortality. Receiver operating characteristic curve (ROC) analysis was used to determine the optimum cut-off values of GAS values to determine the effect on late-mortality. Survival analysis was conducted using Kaplan-Meier. The study included 257 patients with a mean age of 69.75 ± 7.75 (46-92), who underwent EVAR due to AAA. Average follow up period was 18.98 ± 22.84 months (0-88). Fourty-five (17.8%) mortalities occured during long-term follow-up. A past medical history of cancer resulted in a 2.5 fold increase in risk of long-term mortality (OR: 2.52, 95% CI 1.10-5.76; p = 0.029). GAS values were higher in group 2 compared to group 1 (81.02 ± 10.33 vs. 73.73 ± 10.46; p &lt; 0.001). The area under the ROC curve for GAS was 0.682 and the GAS cut-off value was 77.5 (specificity 64%, p &lt; 0.001). The mortality rates in patients with GAS &lt; 77.5 and GAS &gt; 77.5 were: 12.8% and 24.8% respectively (p = 0.014). Every 10 point increase in GAS resulted in approximately a 2 fold increase in risk of long-term mortality (OR: 1.8, 95% CI 1.3-2.5; p &lt; 0.001). Five year survival rates in patients with GAS &lt; 77.5 and &gt; 77.5 were 75.7% and 61.7%, respectively (p = 0.013). The findings of our study suggests that an increase in GAS score may predict long-term mortality. In addition, the mortality rates in patients above the GAS cut-off value almost doubled compared to those below. Furthermore, the presence of a past history of cancer resulted in a 2.5 fold increase in long-term mortality risk. Addition of cancer to the GAS scoring system may be considered in future studies. Further studies are necessary to consolidate these findings.</description><subject>Abdominal aneurysm</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Aortic aneurysm</subject><subject>Aortic Aneurysm, Abdominal - diagnostic imaging</subject><subject>Aortic Aneurysm, Abdominal - mortality</subject><subject>Aortic Aneurysm, Abdominal - surgery</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - mortality</subject><subject>Care and treatment</subject><subject>Decision Support Techniques</subject><subject>Diagnosis</subject><subject>Endovascular</subject><subject>Endovascular Procedures - adverse effects</subject><subject>Endovascular Procedures - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Predictive Value of Tests</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Survival</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1471-2261</issn><issn>1471-2261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptUk1rFTEUHUSxtfoHXEjAjZup-ZhJMi4sj6K1UHChrsOdfIwpmckzmXnl_XvzPix9ICHkcnPOycnlVNVbgi8JkfxjJlQKWmNKymac19tn1TlpBKkp5eT5k_qsepXzPcZESNy9rM5YIzpZyvNqcxMgD_EBrSa7pG0e0Q8dk_2EAK2TNV7PMaHoUIjTUM82jWiMaYbg5y1yMYT44KcB2cnEDWS9BEgo2TX4PQl6E0c_QUBQSF4jOD5y9bp64SBk--Z4XlS_vn75ef2tvvt-c3u9uqt1I_lcc8YobloqXMNBy5Zr3GMteGdJsc841oZ3DmsmJaPcAGgjus4AJmVph9lFdXvQNRHu1Tr5EdJWRfBq34hpULBzFqzCxBHBTV9GaRrOBbi-62nDjOylaUlXtD4ftNZLP1qj7TQnCCeipzeT_62GuFGSY9aKncCHo0CKfxabZzX6rG0IZSxxyYpyjKlsREsK9P0BOkCx5icXi6LewdWKS94IWoZRUJf_QZVl7Oh1nKzzpX9CoAeCTjHnZN2je4LVLlPqkClVMqX2mVLbQnr39N-PlH8hYn8BkXvIfQ</recordid><startdate>20211119</startdate><enddate>20211119</enddate><creator>üzen, Anil</creator><creator>Yilmaz, Metin</creator><creator>YiÄit, Görkem</creator><creator>Civelek, Ä°sa</creator><creator>Türkçü, Mehmet Ali</creator><creator>Çetinkaya, Ferit</creator><creator>Ãnal, Ertekin Utku</creator><creator>Ä°Åcan, Hakki Zafer</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9500-720X</orcidid><orcidid>https://orcid.org/0000-0002-0749-5152</orcidid><orcidid>https://orcid.org/0000-0002-4334-7974</orcidid><orcidid>https://orcid.org/0000-0002-1144-8906</orcidid><orcidid>https://orcid.org/0000-0003-2878-2676</orcidid></search><sort><creationdate>20211119</creationdate><title>Glasgow Aneurysm Score: a predictor of long-term mortality following endovascular repair of abdominal aortic aneurysm?</title><author>üzen, Anil ; Yilmaz, Metin ; YiÄit, Görkem ; Civelek, Ä°sa ; Türkçü, Mehmet Ali ; Çetinkaya, Ferit ; Ãnal, Ertekin Utku ; Ä°Åcan, Hakki Zafer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-633204527f46ac856c0b0c769e1880360cd69f0c388326daacd799da01010cf03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abdominal aneurysm</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Aortic aneurysm</topic><topic>Aortic Aneurysm, Abdominal - diagnostic imaging</topic><topic>Aortic Aneurysm, Abdominal - mortality</topic><topic>Aortic Aneurysm, Abdominal - surgery</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - mortality</topic><topic>Care and treatment</topic><topic>Decision Support Techniques</topic><topic>Diagnosis</topic><topic>Endovascular</topic><topic>Endovascular Procedures - adverse effects</topic><topic>Endovascular Procedures - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Predictive Value of Tests</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Survival</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>üzen, Anil</creatorcontrib><creatorcontrib>Yilmaz, Metin</creatorcontrib><creatorcontrib>YiÄit, Görkem</creatorcontrib><creatorcontrib>Civelek, Ä°sa</creatorcontrib><creatorcontrib>Türkçü, Mehmet Ali</creatorcontrib><creatorcontrib>Çetinkaya, Ferit</creatorcontrib><creatorcontrib>Ãnal, Ertekin Utku</creatorcontrib><creatorcontrib>Ä°Åcan, Hakki Zafer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC cardiovascular disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>üzen, Anil</au><au>Yilmaz, Metin</au><au>YiÄit, Görkem</au><au>Civelek, Ä°sa</au><au>Türkçü, Mehmet Ali</au><au>Çetinkaya, Ferit</au><au>Ãnal, Ertekin Utku</au><au>Ä°Åcan, Hakki Zafer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glasgow Aneurysm Score: a predictor of long-term mortality following endovascular repair of abdominal aortic aneurysm?</atitle><jtitle>BMC cardiovascular disorders</jtitle><addtitle>BMC Cardiovasc Disord</addtitle><date>2021-11-19</date><risdate>2021</risdate><volume>21</volume><issue>1</issue><spage>551</spage><epage>551</epage><pages>551-551</pages><artnum>551</artnum><issn>1471-2261</issn><eissn>1471-2261</eissn><abstract>To evaluate the value of Glasgow Aneurysm Score (GAS) in predicting long-term mortality and survival in patients who have undergone endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). A retrospective single-center study of 257 patients with non-ruptured AAA undergoing EVAR between January 2013 and 2021. GAS scores were compared between the survivors (group 1) and the long-term mortality (group 2) groups. Cox regression analysis was used to determine independent predictors of late mortality. Receiver operating characteristic curve (ROC) analysis was used to determine the optimum cut-off values of GAS values to determine the effect on late-mortality. Survival analysis was conducted using Kaplan-Meier. The study included 257 patients with a mean age of 69.75 ± 7.75 (46-92), who underwent EVAR due to AAA. Average follow up period was 18.98 ± 22.84 months (0-88). Fourty-five (17.8%) mortalities occured during long-term follow-up. A past medical history of cancer resulted in a 2.5 fold increase in risk of long-term mortality (OR: 2.52, 95% CI 1.10-5.76; p = 0.029). GAS values were higher in group 2 compared to group 1 (81.02 ± 10.33 vs. 73.73 ± 10.46; p &lt; 0.001). The area under the ROC curve for GAS was 0.682 and the GAS cut-off value was 77.5 (specificity 64%, p &lt; 0.001). The mortality rates in patients with GAS &lt; 77.5 and GAS &gt; 77.5 were: 12.8% and 24.8% respectively (p = 0.014). Every 10 point increase in GAS resulted in approximately a 2 fold increase in risk of long-term mortality (OR: 1.8, 95% CI 1.3-2.5; p &lt; 0.001). Five year survival rates in patients with GAS &lt; 77.5 and &gt; 77.5 were 75.7% and 61.7%, respectively (p = 0.013). The findings of our study suggests that an increase in GAS score may predict long-term mortality. In addition, the mortality rates in patients above the GAS cut-off value almost doubled compared to those below. Furthermore, the presence of a past history of cancer resulted in a 2.5 fold increase in long-term mortality risk. Addition of cancer to the GAS scoring system may be considered in future studies. Further studies are necessary to consolidate these findings.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>34798809</pmid><doi>10.1186/s12872-021-02366-y</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9500-720X</orcidid><orcidid>https://orcid.org/0000-0002-0749-5152</orcidid><orcidid>https://orcid.org/0000-0002-4334-7974</orcidid><orcidid>https://orcid.org/0000-0002-1144-8906</orcidid><orcidid>https://orcid.org/0000-0003-2878-2676</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2261
ispartof BMC cardiovascular disorders, 2021-11, Vol.21 (1), p.551-551, Article 551
issn 1471-2261
1471-2261
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_01f176db023d4667afb9b243d8b8d519
source Publicly Available Content Database; PubMed Central
subjects Abdominal aneurysm
Aged
Aged, 80 and over
Analysis
Aortic aneurysm
Aortic Aneurysm, Abdominal - diagnostic imaging
Aortic Aneurysm, Abdominal - mortality
Aortic Aneurysm, Abdominal - surgery
Blood Vessel Prosthesis Implantation - adverse effects
Blood Vessel Prosthesis Implantation - mortality
Care and treatment
Decision Support Techniques
Diagnosis
Endovascular
Endovascular Procedures - adverse effects
Endovascular Procedures - mortality
Female
Humans
Male
Middle Aged
Mortality
Predictive Value of Tests
Retrospective Studies
Risk Assessment
Risk Factors
Survival
Time Factors
Treatment Outcome
title Glasgow Aneurysm Score: a predictor of long-term mortality following endovascular repair of abdominal aortic aneurysm?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A08%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glasgow%20Aneurysm%20Score:%20a%20predictor%20of%20long-term%20mortality%20following%20endovascular%20repair%20of%20abdominal%20aortic%20aneurysm?&rft.jtitle=BMC%20cardiovascular%20disorders&rft.au=%C3%BCzen,%20Anil&rft.date=2021-11-19&rft.volume=21&rft.issue=1&rft.spage=551&rft.epage=551&rft.pages=551-551&rft.artnum=551&rft.issn=1471-2261&rft.eissn=1471-2261&rft_id=info:doi/10.1186/s12872-021-02366-y&rft_dat=%3Cgale_doaj_%3EA686472856%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c486t-633204527f46ac856c0b0c769e1880360cd69f0c388326daacd799da01010cf03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2600284751&rft_id=info:pmid/34798809&rft_galeid=A686472856&rfr_iscdi=true